Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 10-Q, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 667 filings
- On EDGAR
- CIK 1720893
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 35
News 8 of 169
Prospectuses and Registrations 8 of 41
- S-8 Registration statement for an employee plan Mar 27, 2026
- 424B5 Prospectus supplement for an offering Mar 11, 2026
- 424B5 Prospectus supplement for an offering Aug 18, 2025
- 424B5 Prospectus supplement for an offering Aug 6, 2025
- S-8 Registration statement for an employee plan Apr 4, 2025
- 424B5 Prospectus supplement for an offering Apr 3, 2025
- 424B5 Prospectus supplement for an offering Mar 4, 2025
- S-3 Shelf registration statement Jan 10, 2025
Proxies 8 of 17
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2025
- PRE 14A Preliminary proxy statement Oct 31, 2025
- DEF 14A Proxy statement for a shareholder vote Dec 30, 2024
- PRE 14A Preliminary proxy statement Dec 18, 2024
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- PRE 14A Preliminary proxy statement Apr 19, 2024
- DEF 14A Proxy statement for a shareholder vote May 17, 2023
Ownership 8 of 362
- 4 Insider reported a trade Aug 14, 2026
- 3 Insider reported their initial holding Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade May 22, 2026
Other 8 of 43
- ARS Annual report sent to shareholders Nov 12, 2025
- EFFECT Notice that a registration became effective Jan 17, 2025
- CORRESP Reply to SEC staff Jan 15, 2025
- UPLOAD Comment letter from SEC staff Jan 15, 2025
- 424B7 Jun 4, 2024
- EFFECT Notice that a registration became effective Jan 22, 2024
- CORRESP Reply to SEC staff Jan 19, 2024
- UPLOAD Comment letter from SEC staff Jan 19, 2024
Everything here comes from BioXcel Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.